Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01574781 · ClinicalTrials.gov registry record
Non-invasive Prenatal Diagnostic Validation Study
A clinical trial, sponsored by Natera.
- Completed
- Registry status
- 1,781
- Enrollment target
NCT01574781: Completed study, sponsored by Natera.
NCT01574781 is a clinical trial that has completed, run by Natera. The registered enrollment target is 1,781 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01574781 has completed, sponsored by Natera.
- COMPLETED
- Registry status
- 1,781 participants
- Enrollment target
Study Summary
The primary purpose of this study is to collect maternal blood samples from pregnant women to develop a non-invasive prenatal diagnostic test based on fetal DNA isolated from maternal blood.
Primary Outcome
Maternal plasma will be drawn at the time at which they present while pregnant as long as they are at least 6 weeks along. Additional samples (for confirmation of chromosome makeup) may also be drawn on that fetus when fetal sampling is possible (termination, miscarriage) or on the child at or shortly after birth.
Interventions
- PROCEDURE Blood draw
- PROCEDURE Cheek swab/Saliva Sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,781 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-04 |
What the finished NCT01574781 record still lists
NCT01574781 is an observational study that tracks outcomes without assigning an intervention. Its 1,781 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Blood draw is the first listed.
NCT01574781 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01574781 about?
NCT01574781 is a clinical study titled "Non-invasive Prenatal Diagnostic Validation Study". The primary purpose of this study is to collect maternal blood samples from pregnant women to develop a non-invasive prenatal diagnostic test based on fetal DNA isolated from maternal blood.
What is the current status of trial NCT01574781?
This trial is currently completed. The enrollment target is 1,781 participants. The study started on 2011-09. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01574781?
The interventions under investigation include: Blood draw (PROCEDURE), Cheek swab/Saliva Sampling (PROCEDURE).
Who is sponsoring clinical trial NCT01574781?
This trial is sponsored by Natera, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03067181 · 1,780 participants · Phase 3
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- NCT06526650 · 1,780 participants · NA
'Ai Pono Cooking Demonstrations
- NCT05770570 · 1,785 participants · Phase 2
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
- NCT06239688 · 1,764 participants · NA
Evaluating a National Person-Centered Training Program to Strengthen the Dementia Care Workforce
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia